BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04680052-completion@plaintrial.com
DTSTAMP:20261027T192607Z
DTSTART;VALUE=DATE:20280809
SUMMARY:A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus L
 enalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituxi
 mab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marg
 inal Zone Lymphoma. — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04680052
URL:https://plaintrial.com/trial/NCT04680052
END:VEVENT
END:VCALENDAR